Williams, W. R. (2025) Nucleotide Relative Molecular Similarity within Anti-Psychotic Drug Structures. Journal of Biosciences and Medicines, 13, 106-117. doi: 10.4236/jbm.2025.136010 .

PFAS are, in many ways, remarkable molecules. Even a thin layer can repel water, oil, and dirt. They are also highly ...

Imagine being tasked with baking a soufflé, except the only instruction provided is an ingredient list without any ...

Formaldehyde has been linked to cancer — but the chemical, and preservatives that release it, are often added to personal care products to extend their shelf life. And new research found this ...

Structure content for AI search so it’s easy for LLMs to cite. Use clarity, formatting, and hierarchy to improve your visibility in AI results. In the SEO world, when we talk about how to ...

The trial will evaluate pirfenidone capsules for the treatment of radiation-induced lung injury (RILI), with or without immune-related pneumonitis (CIP). This regulatory milestone marks the ...

This report on Pirfenidone provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological ...

McCurry said the chemical structure of the compound has some “exotic features” that make him suspicious that it could be toxic. He also noted that chloramine disinfection can have some other ...

Discover comprehensive details about Pirfenidone, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

CAMBRIDGE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening ...

An industrial chemical used in plastic products has been cropping up in illegal drugs from California to Maine, a sudden and puzzling shift in the drug supply that has alarmed health researchers.

Mortality rates were also concerning, with IPF-related deaths at 13.4% for pirfenidone and 7.2% for nintedanib, while all-cause mortality was 20.1% for pirfenidone and 16.6% for nintedanib.